Outcomes of deep brain stimulation lead revision surgeries for Parkinson's disease

Yu Ma,Rongsong Zhou,Suhua Miao,Yuan Yang
DOI: https://doi.org/10.3760/cma.j.issn.1001-2346.2019.11.012
2019-01-01
Abstract:Objective To study the outcomes of the revision surgeries correcting electrode malposition in deep brain stimulation (DBS) for Parkinson's disease (PD).Methods A total of 18 PD patients were enrolled who underwent lead revision surgeries due to subthalamic nucleus (STN) DBS lead malposition at Neuromodulation Center,Department of Neurosurgery,Tsinghua University Yuquan Hospital between September 2013 and May 2018.Changes in UPDRS-Ⅲ scores on and off medication were analyzed at 1 month and 6 months postoperatively compared to those before surgery.MR images were also collected to analyze the lead location change.Results Among the 18 patients,14 had bilateral lead revision and 4 had unilateral revision.A total of 32 leads were revised,among which 25 were reimplanted and the other 7 were repositioned without reimplantation.Off medication,the average UPDRS-Ⅲ scores before and 1 month and 6 months after surgery were 44.0 ± 10.5,22.4 ± 7.4 and 25.3 ± 7.7 respectively.On medication,those were 27.3 ± 9.1,16.7 ± 8.7 and 20.3 ± 8.3 respectively.The analysis of variance and comparisons between groups showed that the on and off medication scores were significantly reduced after the revision surgery (P < 0.05).The off medication score at 6 months was averagely improved by (40.7 ± 4.7) % (5.9-79.5%).The average distance between pre-implantation and post-implantation lead locations on the plane 3.5 mm below AC (anterior commissure)-PC (posterior commissure) was (2.8 ± 1.0) mm (1.2-4.5 mm).No adverse events such as hemorrhage or infection were observed after surgery.Conclusion Lead revision surgery could safely and effectively remedy the suboptimal outcomes due to electrode malposition in STN-DBS for PD patients.
What problem does this paper attempt to address?